Key Takeaways and Clinical Pearls on the Treatment of R/R MM in the Era of Bispecifics

Opinion
Video

The panel concludes its discussion with key takeaways on the evolving treatment landscape for multiple myeloma.

Recent Videos
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Related Content